Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · IEX Real-Time Price · USD
3.080
-0.120 (-3.75%)
Jul 2, 2024, 4:30 PM EDT - Market closed
Minerva Neurosciences Market Cap
Minerva Neurosciences has a market cap or net worth of $21.54 million as of July 2, 2024. Its market cap has decreased by -36.65% in one year.
Market Cap
21.54M
Enterprise Value
-13.38M
1-Year Change
-36.65%
Ranking
Category
Stock Price
$3.08
Market Cap Chart
Since July 1, 2014, Minerva Neurosciences's market cap has decreased from $110.60M to $21.54M, a decrease of -80.52%. That is a compound annual growth rate of -15.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 22.10M | -48.60% |
| Dec 29, 2023 | 43.00M | 405.88% |
| Dec 30, 2022 | 8.50M | -75.15% |
| Dec 31, 2021 | 34.20M | -65.77% |
| Dec 31, 2020 | 99.90M | -64.00% |
| Dec 31, 2019 | 277.50M | 5.92% |
| Dec 31, 2018 | 262.00M | 11.92% |
| Dec 29, 2017 | 234.10M | -42.76% |
| Dec 30, 2016 | 409.00M | 172.49% |
| Dec 31, 2015 | 150.10M | 35.23% |
| Dec 31, 2014 | 111.00M | 0.36% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apollomics | 23.14M |
| Gain Therapeutics | 23.11M |
| Aptorum Group | 22.70M |
| Unity Biotechnology | 22.67M |
| Oncternal Therapeutics | 22.49M |
| NeuroOne Medical Technologies | 22.27M |
| Nephros | 22.25M |
| Aprea Therapeutics | 22.10M |